The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 11110 malaria professionals are enjoying the free benefits of MalariaWorld today

immunogenicity analysis

Immunogenicity analysis of conserved fragments in Plasmodium ovale species merozoite surface protein 4

March 31, 2020 - 15:25 -- Open Access
Author(s): 
Juliette Uwase, Ruilin Chu, Kokouvi Kassegne, Yao Lei, Feihu Shen, Haitian Fu, Yifan Sun, Yinghua Xuan, Jun Cao and Yang Cheng
Reference: 
Malaria Journal 2020 19:126, 30 March 2020

There is an urgent need for an effective vaccine to control and eradicate malaria, one of the most serious global infectious diseases. Plasmodium merozoite surface protein 4 (MSP4) has been listed as a blood-stage subunit vaccine candidate for malaria. Infection with Plasmodium ovale species including P. ovale wallikeri and P. ovale curtisi, is also a source of malaria burden in tropical regions where it is sometimes mixed with other Plasmodium species. However, little is known about P. ovale MSP4.

Subscribe to RSS - immunogenicity analysis